Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Ovarian Epithelial × durvalumab × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 26 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 14 Cholangiocarcinoma 13 Biliary Tract Neoplasms 13 Small Cell Lung Carcinoma 11 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Liver Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma 4 Stomach Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Gallbladder Neoplasms 3 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Bile Duct Neoplasms 2 Advanced Biliary Tract Cancer 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Adenocarcinoma 2 Vaccinia 1 Unresectable Hepatocellular Carcinoma 1 SCLC, Limited Stage 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1

Interventions

Paclitaxel 10 pembrolizumab 5 Carboplatin 5 Bevacizumab 5 olaparib 3 liposomal doxorubicin 3 ribociclib 2 palbociclib 2 mirvetuximab soravtansine 2 fludarabine 2 Topotecan 2 Letrozole 2 Fulvestrant 2 Cyclophosphamide 2 Blood Specimen Collection 2 trastuzumab deruxtecan 1 sacituzumab govitecan 1 pegfilgrastim 1 niraparib 1 lenvatinib 1 isoquercitrin 1 fludarabine phosphate 1 durvalumab 1 denileukin diftitox 1 cemiplimab 1 abemaciclib 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 SLC25A33 protein, human 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04644289 2025-10-03

WoO

AGO Research GmbH

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡